vimarsana.com
Home
Live Updates
GlycoMimetics, Inc. (NASDAQ:GLYC) Q4 2023 Earnings Call Transcript : comparemela.com
GlycoMimetics, Inc. (NASDAQ:GLYC) Q4 2023 Earnings Call Transcript
Operator: Good morning, and thank you for joining the GlycoMimetics Q4 and Full Year 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Related Keywords
United States ,
American ,
Tara Bancroft ,
Christian Dinneen ,
Bruce Johnson ,
Brian Hahn ,
Harout Semerjian ,
Naureen Quibria ,
Children Oncology Group Phase ,
Company Counsel At Glycomimetics ,
Glycomimetics Inc ,
Pediatric Early Phase Clinical Trial Network ,
Nasdaq ,
Dana Farber Cancer Institute ,
American Cancer Society ,
National Cancer Institute ,
Alliance For Clinical Trials In Oncology ,
American Society Of Hematology Research Collaborative ,
Call Transcript March ,
Full Year ,
Christian Dinneen Long ,
Company Counsel ,
Chief Executive Officer ,
Chief Financial Officer ,
Edwin Rock ,
Chief Medical Officer ,
Chief Commercial ,
Clinical Trials ,
Early Phase Clinical Trial ,
American Society ,
Hematology Research ,
Wall Street Lower Ratings ,
Capital One ,
comparemela.com © 2020. All Rights Reserved.